(1 - 16 from 17
)
Michael Ezekowitz Leaves Lankenau to Join Cardiovascular Research...
article.wn.com
Michael Ezekowitz is leaving the Lankenau Institute for Medical Research in Philadelphia to join the Cardiovascular Research Foundation ...
Pre-treatment with rivaroxaban may expedite cardioversion
medicalxpress.com
... required to achieve adequate anticoagulation," noted co-principal investigator Michael Ezekowitz MD , PhD, from the Sidney Kimmel Medical ...
Michael-Ezekowitz - Cardiac Rhythm News
cardiacrhythmnews.com
Michael-Ezekowitz. Cardiac Rhythm News. Write to us. Editorial: Angela O'Neill . Advertising: Elizabeth Sutherst ...
sorted by relevance / date